HC Wainwright Weighs in on Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP) – Analysts at HC Wainwright issued their FY2029 earnings per share estimates for Edap Tms in a report issued on Friday, March 28th. HC Wainwright analyst S. Ramakanth forecasts that the medical equipment provider will post earnings of $0.40 per share for the year. HC Wainwright has a “Buy” rating and a $19.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%.

A number of other research firms have also recently weighed in on EDAP. StockNews.com initiated coverage on Edap Tms in a report on Friday, March 28th. They issued a “hold” rating for the company. Piper Sandler cut their target price on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th.

Edap Tms Stock Performance

Shares of EDAP opened at $1.96 on Monday. The firm has a 50 day simple moving average of $2.41 and a 200-day simple moving average of $2.48. The stock has a market cap of $72.72 million, a price-to-earnings ratio of -3.02 and a beta of 0.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 1-year low of $1.90 and a 1-year high of $8.50.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Illumine Investment Management LLC purchased a new stake in shares of Edap Tms in the fourth quarter valued at $50,000. BNP Paribas Financial Markets boosted its stake in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares during the last quarter. Jane Street Group LLC boosted its stake in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares during the last quarter. Millennium Management LLC grew its holdings in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after buying an additional 33,558 shares during the period. Finally, Orion Capital Management LLC increased its stake in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.